Table of Contents
ISRN Gastroenterology
Volume 2014, Article ID 863206, 6 pages
http://dx.doi.org/10.1155/2014/863206
Research Article

Association of Symptoms of Gastroesophageal Reflux with Metabolic Syndrome Parameters in Patients with Endocrine Disease

1Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan
2Department of Preventive Medicine, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan

Received 14 November 2013; Accepted 11 December 2013; Published 30 January 2014

Academic Editors: G. Barbaro and V. Savarino

Copyright © 2014 Masatoshi Nomura et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, “Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III),” Journal of the American Medical Association, vol. 285, no. 19, pp. 2486–2497, 2001. View at Google Scholar · View at Scopus
  2. M. A. Cornier, D. Dabelea, T. L. Hernandez et al., “The metabolic syndrome,” Endocrine Reviews, vol. 29, no. 7, pp. 777–822, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. P. Sharma, S. Wani, Y. Romero, D. Johnson, and F. Hamilton, “Racial and geographic issues in gastroesophageal reflux disease,” American Journal of Gastroenterology, vol. 103, no. 11, pp. 2669–2680, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. I. Wiklund, “Review of the quality of life and burden of illness in gastroesophageal reflux disease,” Digestive Diseases, vol. 22, no. 2, pp. 108–114, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. E. M. Quigley, “Review article: gastric emptying in functional gastrointestinal disorders,” Alimentary Pharmacology and Therapeutics, vol. 20, supplement 7, pp. 56–60, 2004. View at Google Scholar · View at Scopus
  6. G. Shi, S. Bruley des Varannes, C. Scarpignato, M. Le Rhun, and J.-P. Galmiche, “Reflux related symptoms in patients with normal oesophageal exposure to acid,” Gut, vol. 37, no. 4, pp. 457–464, 1995. View at Google Scholar · View at Scopus
  7. R. H. Jones and G. Baxter, “Lansoprazole 30 mg daily versus ranitidine 150 mg b.d. in the treatment of acid-related dyspepsia in general practice,” Alimentary Pharmacology and Therapeutics, vol. 11, no. 3, pp. 541–546, 1997. View at Google Scholar · View at Scopus
  8. N. Vakil, S. V. van Zanten, P. Kahrilas et al., “The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus,” American Journal of Gastroenterology, vol. 101, no. 8, pp. 1900–1943, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Ronkainen, P. Aro, T. Storskrubb et al., “High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: a Kalixanda study report,” Scandinavian Journal of Gastroenterology, vol. 40, no. 3, pp. 275–285, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Kusano, Y. Shimoyama, S. Sugimoto et al., “Development and evaluation of FSSG: frequency scale for the symptoms of GERD,” Journal of Gastroenterology, vol. 39, no. 9, pp. 888–891, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Kusano, Y. Shimoyama, O. Kawamura et al., “Proton pump inhibitors improve acid-related dyspepsia in gastroesophageal reflux disease patients,” Digestive Diseases and Sciences, vol. 52, no. 7, pp. 1673–1677, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. E. H. Hoogendoorn and B. M. Cools, “Hyperthyroidism as a cause of persistent vomiting,” Netherlands Journal of Medicine, vol. 62, no. 8, pp. 293–296, 2004. View at Google Scholar · View at Scopus
  13. H. Noto, T. Mitsuhashi, S. Ishibashi, and S. Kimura, “Hyperthyroidism presenting as dysphagia,” Internal Medicine, vol. 39, no. 6, pp. 472–473, 2000. View at Google Scholar · View at Scopus
  14. G. Johannsson and B.-Å. Bengtsson, “Growth hormone and the metabolic syndrome,” Journal of Endocrinological Investigation, vol. 22, no. 5, pp. 41–46, 1999. View at Google Scholar · View at Scopus
  15. L. Murray, B. Johnston, A. Lane et al., “Relationship between body mass and gastro-oesophageal reflux symptoms: the Bristol Helicobacter Project,” International Journal of Epidemiology, vol. 32, no. 4, pp. 645–650, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. S. J. Chung, D. Kim, M. J. Park et al., “Metabolic syndrome and visceral obesity as risk factors for reflux oesophagitis: a cross-sectional case-control study of 7078 Koreans undergoing health check-ups,” Gut, vol. 57, no. 10, pp. 1360–1365, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. D. B. Carr, K. M. Utzschneider, R. L. Hull et al., “Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome,” Diabetes, vol. 53, no. 8, pp. 2087–2094, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Xu, G. T. Barnes, Q. Yang et al., “Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance,” Journal of Clinical Investigation, vol. 112, no. 12, pp. 1821–1830, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Watanabe, M. Hojo, and A. Nagahara, “Metabolic syndrome and gastrointestinal diseases,” Journal of Gastroenterology, vol. 42, no. 4, pp. 267–274, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. N. Barak, E. D. Ehrenpreis, J. R. Harrison, and M. D. Sitrin, “Gastro-oesophageal reflux disease in obesity: pathophysiological and therapeutic considerations,” Obesity Reviews, vol. 3, no. 1, pp. 9–15, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Verhelst, A. F. Mattsson, A. Luger et al., “Prevalence and characteristics of the metabolic syndrome in 2479 hypopituitary patients with adult-onset GH deficiency before GH replacement: a KIMS analysis,” European Journal of Endocrinology, vol. 165, no. 6, pp. 881–889, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. A. F. Attanasio, D. Mo, E. M. Erfurth et al., “Prevalence of metabolic syndrome in adult hypopituitary growth hormone (GH)-deficient patients before and after GH replacement,” Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 1, pp. 74–81, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Daher, T. Yazbeck, J. B. Jaoude, and B. Abboud, “Consequences of dysthyroidism on the digestive tract and viscera,” World Journal of Gastroenterology, vol. 15, no. 23, pp. 2834–2838, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. B. Pfaffenbach, R. J. Adamek, D. Hagelmann, J. Schaffstein, and M. Wegener, “Effect of hyperthyroidism on antral myoelectrical activity, gastric emptying and dyspepsia in man,” Hepato-Gastroenterology, vol. 44, no. 17, pp. 1500–1508, 1997. View at Google Scholar · View at Scopus
  25. M. A. Blank, A. B. R. Thomson, A. Leung, and F. Lanza, “Simultaneous occurrence of inflammatory bowel disease and thyroid disease,” American Journal of Gastroenterology, vol. 96, no. 6, pp. 1925–1926, 2001. View at Publisher · View at Google Scholar · View at Scopus
  26. E. Savarino, P. Zentilin, E. Marabotto et al., “Overweight is a risk factor for both erosive and non-erosive reflux disease,” Digestive and Liver Disease, vol. 43, no. 12, pp. 940–945, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. E. Savarino, D. Pohl, P. Zentilin et al., “Functional heartburn has more in common with functional dyspepsia than with non-erosive reflux disease,” Gut, vol. 58, no. 9, pp. 1185–1191, 2009. View at Publisher · View at Google Scholar · View at Scopus